3WK-33413-64915
2 vaccinations
4 coded responses
26 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 492 / MI
- Registered
- 2021-03-24
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Registered in v-safe
-
2021-03-24
Dose 1 — Moderna
- 2021-03-24
-
2021-03-25
Survey response — days 1–6 daily, dose 1MedDRA: Chills — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Overnight, severe, teeth chattering chills and shivering. Not as bad during the day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, HeadacheAdult check-in
- 2021-03-27
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-14
-
2021-04-21
Dose 2 — Moderna
- 2021-04-21
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-04-23
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Loss of personal independence in daily activities, Myalgia, Pain — Feeling: Good · Site: Pain · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Better today, but extremely difficult to do yoga. Brought back chills and muscle, body aches.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-05-07
- 2021-05-12
- 2021-05-19
- 2021-05-27
- 2021-06-02
- 2021-07-21
-
2021-10-20
Survey response — 6 months, dose 2MedDRA: Adenomyosis, Heavy menstrual bleeding, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: diagnosed with adenomyosis. very heavy and lengthy period, especially the one after the 2nd dose. unsure if prolonged cough is related, could be from initial covid infection in january. · Healthcare visit (other): Normal doctors officeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-20
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-10-25
-
2022-04-23
Survey response — 12 months, dose 2MedDRA: Adrenal disorder, Fatigue, Gluten sensitivity, Hypersensitivity — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Adrenal fatigue, gluten and casin sensitivityMedDRA releases: 2024-11 · check-in free text available
-
2022-04-23
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-25
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Moderna | |
| 2 | 2021-04-21 | Moderna |
Call center
2 call center cases
2 successful
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Overnight, severe, teeth chattering chills and shivering. Not as bad during the day.
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Better today, but extremely difficult to do yoga. Brought back chills and muscle, body aches.
Release 10 — 6 months, dose 2
Symptoms: diagnosed with adenomyosis. very heavy and lengthy period, especially the one after the 2nd dose. unsure if prolonged cough is related, could be from initial covid infection in january.
Healthcare visit (other): Normal doctors office
Release 11 — 12 months, dose 2
Symptoms: Adrenal fatigue, gluten and casin sensitivity
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Adenomyosis | · | · | ✓ |
| SD | Adrenal disorder | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gluten sensitivity | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Chills | ✓ | ✓ | ✓ |
| SRO | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release